100 resultsfor "XENOTHERAPEUTICS"

Research in the field of xeno-transplantation; Biotechnology research; Scientific research

Anti-aging therapy; Anti-aging services; Anti-aging research; Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Peptides for use in age-related diseases and cancer; Peptides for use in skin conditions; Anti-aging peptides; Peptides for use in prevention of radiation damage; Peptides for use in treatment of radiation damage; Peptides for use in prevention of radiation related diseases; Peptides for use in treatment of radiation related diseases; Peptides for use in treatment of obesity; Peptides for use in weight loss regimens, Peptides for use in treatment of obesity in combination with other drugs; Gene therapy research; Gene therapy research related to anti-aging; Gene therapy research related to cancer; Gene therapy related to prevention and treatment of radiation damage and radiation related diseases; Gene therapy related to treatment of obesity; Gene therapy related to weight loss regimens; Gene therapy related to treatment of obesity in combination with other drugs; Biologic age scoring; Statistical scoring to determine a biologic age score of a patient; Medical services; Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of age-related disorders; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Biopsy services; Biopsy services related to biologic age; Biopsy services related to biological age scoring; Biopsy services related to determining a number or percentage of senescent cells; Laboratory services; Laboratory services related to biologic age; Laboratory services related to biological age scoring; Laboratory services related to determining a number or percentage of senescent cells; Non-invasive testing; Non-invasive testing related to biologic age; Non-invasive testing related to biological age scoring; Non-invasive testing related to determining a number or percentage of senescent cells; Prevention of radiation damage; Treatment of radiation damage; Prevention of radiation related diseases; Treatment of radiation related diseases; Treatment of obesity; Weight loss regimens; Treatment of obesity in combination with other drugs; Anti-aging cream; Anti-aging serum; Cosmetic anti-aging products; Cosmetic preparations; Cosmetic research; Cosmetic creams for skin care; Cosmetic preparations for skin care; Peptides for use in cosmetics; Anti-aging peptides for use in cosmetics; Development of cosmetic preparations; Research and development of cosmetic preparations; Consulting services in the fields of anti-aging and cosmetics; Biologic age scoring for use in cosmetics; Statistical scoring to determine a biologic age score of an individual

Pharmaceutical products and preparations; polyclonal antibodies for medical, pharmaceutical and veterinary use; monoclonal antibodies for medical, pharmaceutical and veterinary use; diagnostic preparations and diagnostic biomarker reagents for medical use; chemical and biological preparations for medical or pharmaceutical use; chemical reagents for medical or veterinary use.

"THERAPEUTICS"; Scientific research and development in the field of oncology; Providing medical and scientific research, namely, conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of oncology

Class 005: Pharmaceutical preparations for the protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; pharmaceutical preparations, in particular, chemical and biological preparations for medical purposes, namely, for the protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposes, namely, pharmaceutical preparations for the protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; immunotherapeutic drugs namely, pharmaceutical preparations for the protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; excluding preparations for RNA-based gene silencing; Class 009: Downloadable computer software for use in collecting, analyzing and organizing data in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; downloadable computer software for use in collecting, analyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collecting, analyzing and organizing data in the field of antibodies; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualization, namely, scientific analysis of genetic sequences; downloadable software for the managing, analysis, and visualization of biological data; excluding software and devices for RNA-based gene silencing and hepatocyte-specific computational biology; Class 042: Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infections, cancer, disease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software platforms; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; software as a service (SAAS) services featuring DNA analysis software; provision of online non-downloadable software for the management, visualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; excluding services related to RNA-based gene silencing and hepatocyte-specific computational biology; Class 044: Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories

Computerized on-line retail store services in the field of nutraceuticals and cosmetic products

Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system, the immune system, the metabolic system, the musculo-skeletal system, the cardiovascular system, the respiratory system, infectious diseases, obesity, incontinence, cancer, inflammation and inflammatory diseases, auto-immune diseases, blood diseases, tumors, multiple sclerosis, ulcerative colitis, arthritis, and skin disease; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in biotechnological product development; "THERAPEUTICS"; Biotechnology research; Pharmaceutical research and development; Testing of pharmaceuticals

Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid; Downloadable and recorded computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the fields of pharmaceuticals, medicines and drug discovery; downloadable computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; recorded computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; downloadable databases in the field of pharmaceuticals, medicines and drug discovery; electronic databases recorded on computer media, for use in the field of pharmaceuticals, medicines and drug discovery; downloadable and recorded computer platform software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations; downloadable and recorded computer software platforms for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the fields of pharmaceuticals, medicines and drug discovery; Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; short interfering RNA (siRNA) medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; "THERAPEUTICS"; Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking gene expression, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; drug discovery services; drug discovery services relating to RNAi-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; drug discovery services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; human genetic research; scientific and technical data analysis in the field of pharmaceuticals, medicines and drug discovery; scientific and technical data analysis in relation to pharmaceuticals and medicines; scientific and technical data analysis in relation to RNAi-based medicines; scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific and technical data analysis in relation to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design, development, creation and maintenance of computer platforms and computer software; design, development, creation and maintenance of computational computer software platforms; design, development, creation and maintenance of computer software platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) featuring computer software platforms for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for use in the field of pharmaceuticals, medicines and drug discovery, for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations; Platform as a Service (PaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for use in the field of pharmaceuticals, medicines, and drug discovery, for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating RNAi-based medicines and pharmaceuticals, short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design and development of computer-simulated models; design of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery; providing temporary use of online non-downloadable computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the field of pharmaceuticals, medicines and drug discovery; providing temporary use of online non-downloadable computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS); Software as a Service (SaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for use in the field of pharmaceuticals, medicines and drug discovery, namely, for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and generating pharmaceutical and medical preparations; Software as a Service (SaaS) services featuring computer software platforms using artificial intelligence and machine learning for use in the field of pharmaceuticals, medicines and drug discovery, namely, for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating RNAi-based medicines and pharmaceuticals, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid

Pharmaceutical and medical preparations for use in targeting genes and silencing or inhibiting gene expression; RNAi-based medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; short interfering RNA (siRNA) medicines and pharmaceuticals for use in targeting genes and blocking, silencing, or inhibiting gene expression, and for use in targeting mRNA and triggering its degradation; nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; none of the aforementioned goods for, or related to, T-cells or T-cell receptors | Downloadable and recorded computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the fields of pharmaceuticals, medicines and drug discovery; downloadable computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; recorded computer software using artificial intelligence for machine learning for use in the field of pharmaceuticals, medicines and drug discovery; downloadable databases in the field of pharmaceuticals, medicines and drug discovery; electronic databases recorded on computer media, for use in the field of pharmaceuticals, medicines and drug discovery; downloadable and recorded computer platform software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations; downloadable and recorded computer software platforms for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the fields of pharmaceuticals, medicines and drug discovery; none of the aforementioned goods for, or related to, T-cells or T-cell receptors | Custom manufacture of pharmaceutical and medical preparations; custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid; none of the aforementioned services for, or related to, T-cells or T-cell receptors | Scientific research and development; pharmaceutical research and development services; scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking gene expression, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; drug discovery services; drug discovery services relating to RNAi-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; drug discovery services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; human genetic research; scientific and technical data analysis in the field of pharmaceuticals, medicines and drug discovery; scientific and technical data analysis in relation to pharmaceuticals and medicines; scientific and technical data analysis in relation to RNAi-based medicines; scientific and technical data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific and technical data analysis in relation to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design, development, creation and maintenance of computer platforms and computer software; design, development, creation and maintenance of computational computer software platforms; design, development, creation and maintenance of computer software platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) featuring computer software platforms for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for use in the field of pharmaceuticals, medicines and drug discovery, for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations; Platform as a Service (PaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for use in the field of pharmaceuticals, medicines, and drug discovery, for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating RNAi-based medicines and pharmaceuticals, short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design and development of computer-simulated models; design of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery; providing temporary use of online non-downloadable computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the field of pharmaceuticals, medicines and drug discovery; providing temporary use of online non-downloadable computer software for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating pharmaceutical and medical preparations, for use in the field of pharmaceuticals, medicines and drug discovery; Software as a Service (SaaS); Software as a Service (SaaS) services featuring computer software platforms using artificial intelligence and machine learning software and databases for use in the field of pharmaceuticals, medicines and drug discovery, namely, for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and generating pharmaceutical and medical preparations; Software as a Service (SaaS) services featuring computer software platforms using artificial intelligence and machine learning for use in the field of pharmaceuticals, medicines and drug discovery, namely, for modelling genetic sequences and gene-disease associations, and for identifying and ranking potential gene targets, and for generating RNAi-based medicines and pharmaceuticals, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid; none of the aforementioned services for, or related to, T-cells or T-cell receptors

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development

Class 001: Cells for scientific, laboratory or medical research; Class 042: Licensing of intellectual property, namely technology used in the development and manufacture of pharmaceuticals

"THERAPEUTICS"; biopharmaceutical development services in the field of development of therapies for dermatological disorders, including atopic dermatitis, eczema, chronic wounds, psoriasis, asthma, acne, diabetic foot ulcers, diabetic wounds, chronic diabetic wound healing, treatment and reduction of post-procedure infections; biopharmaceutical development services in the field of development of drugs, treatments, and therapeutics for acceleration of dermatological healing; biopharmaceutical development services in the field of development of vaccines for treatment of viruses and diseases; biopharmaceutical development services in the field of development of drugs, treatments, and therapeutics for immunotherapy

Printed publications, namely journals and newsletters in the field of the neurosciences and treatments of disorders of the nervous system | Providing online publications in the nature of journals and newsletters in the field of the neurosciences and treatments of disorders of the nervous system

Class 042: identification and development of, therapeutic targets, namely, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, namely, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; Scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer

Therapeutics in the nature of cells, proteins and protein complexes for the treatment and prevention of cancer, inflammation, and inflammatory diseases; biotherapeutics for the treatment and prevention of cancer, inflammation, and inflammatory diseases; medicines for the treatment and prevention of cancer, inflammation, and inflammatory diseases; pharmaceutical products for the treatment and prevention of cancer, inflammation, and inflammatory diseases; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutic cells, therapeutic proteins and therapeutic antibodies for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; therapeutics and cell therapies in the nature of cells, proteins and protein complexes for the treatment of cancer, inflammation, and inflammatory diseases; engineered cell therapies in the nature of cells, proteins and protein complexes for medical purposes, namely, the treatment and prevention of cancer, inflammation and inflammatory diseases; engineered cell therapy platforms consisting of modified cells, cell receptors, proteins and protein complexes; cell platforms consisting of modified cells, cell receptors, proteins and protein complexes for the treatment and prevention of cancer, inflammation and inflammatory diseases; technology platforms for developing and engineering therapeutic cells, therapeutic proteins, therapeutic antibodies, therapeutics and cellular therapies for the treatment and prevention of cancer, inflammation, and inflammatory diseases; platform for autologous and allogeneic cell manufacturing; therapeutics and cell therapies targeting targets lost in tumors for the treatment and prevention of cancer, inflammation and inflammatory diseases; gene therapy products, namely, genetically engineered tissues for transplant purposes; BIOTHERAPEUTICS

Class 042: Pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases

Class 042: Pharmaceutical drug development services

pharmaceutical preparations for the prevention and treatment of diseases and disorders, namely, cancer and tumors; pharmaceutical preparations for the treatment of immune system related diseases and disorders; "THERAPEUTICS"; pharmaceutical research and development services

Dietary supplements

Pharmaceutical preparations for myeloprotection and anti-tumor effects; pharmaceutical preparations for reducing side effects of chemotherapy; pharmaceutical preparations for use in oncology, improving outcomes from chemotherapy, and treatment of cancer; therapeutic preparations for use in patients with cancer; "THERAPEUTICS"; Pharmaceutical research and development; providing medical and scientific research information in the fields of oncology, pharmaceuticals, therapies, diseases, and disorders

Pharmaceutical preparations for myeloprotection and anti-tumor effects; pharmaceutical preparations for reducing side effects of chemotherapy; pharmaceutical preparations for use in oncology, improving outcomes from chemotherapy, and treatment of cancer; therapeutic preparations for use in patients with cancer; "THERAPEUTICS"; Pharmaceutical research and development; providing medical and scientific research information in the fields of oncology, pharmaceuticals, therapies, diseases, and disorders

Pharmaceutical products for the prevention and treatment of disease, namely, cancer, autoimmune diseases and immunological diseases; therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals being medicines comprised of small molecules, cell therapies, nucleic acids and biologics for treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunology; Pharmaceutical research and development; scientific research and development; medical research; development in the field of medical products and preparations; medical research, development, manufacturing and commercialization services in the fields of drug discovery, oncology, auto-immunity and immunology; development of manufacturing methods for others for pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunology

Class 020: Beds for household pets; Dog beds; Pet furniture; Pet cushions; Portable beds for pets; Sofas for pets

Class 042: Pharmaceutical research services in the field of anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for the treatment of eye diseases and conditions, ocular pharmaceuticals, ophthalmic preparations, pharmaceutical preparations for use in chemotherapy, antivirals, pharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting metabolism, pharmaceutical products for treating respiratory diseases; development of anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for the treatment of eye diseases and conditions, ocular pharmaceuticals, ophthalmic preparations, pharmaceutical preparations for use in chemotherapy, antivirals, pharmaceutical preparations acting on the central nervous system, pharmaceutical agents affecting metabolism, pharmaceutical products for treating respiratory diseases

Class 005: Pharmaceutical preparations for the treatment of neurological, immunological, nephrological, oncological, infectious, cardiovascular, vascular, central and peripheral nervous system, autoimmune, endocrinological, gastrointestinal, genetic, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, ocular, neuromuscular, and viral diseases, conditions and disorders

Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Natural supplements for treating depression and anxiety; Vitamin and mineral supplements; "THERAPEUTICS"

Class 005: Biological and pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use in the nature of biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases; Class 042: Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics

Class 042: Pharmaceutical products development

Class 005: Pharmaceutical preparations for the protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; pharmaceutical preparations, in particular, chemical and biological preparations for medical purposes, namely, for the protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposes, namely, pharmaceutical preparations for the protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; immunotherapeutic drugs namely, pharmaceutical preparations for the protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; excluding preparations for RNA-based gene silencing; Class 009: Downloadable computer software for use in collecting, analyzing and organizing data in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; downloadable computer software for use in collecting, analyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collecting, analyzing and organizing data in the field of antibodies; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualization, namely, scientific analysis of genetic sequences; downloadable software for the managing, analysis, and visualization of biological data; excluding software and devices for RNA-based gene silencing and hepatocyte-specific computational biology; Class 042: Scientific and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infections, cancer, disease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software platforms; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; software as a service (SAAS) services featuring DNA analysis software; provision of online non-downloadable software for the management, visualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; excluding services related to RNA-based gene silencing and hepatocyte-specific computational biology; Class 044: Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories

Class 042: Pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer, all of the foregoing excluding research and development services for pharmaceutical products for sleep disorders, central nervous disorders (other than cancers of the central nervous system), and neurological disorders (other than cancers of the neurological system)

Class 005: Pharmaceutical products for the treatment of cancer, all of the foregoing excluding pharmaceutical products for sleep disorders, central nervous disorders other than cancers of the central nervous system, and neurological disorders other than cancers of the neurological system

Medical services; "IMMUNOTHERAPEUTICS"; Biological research; Biotechnology research; Database design and development; Design and development of computer software; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Pharmaceutical research services; Scientific and technological services, namely, research and design in the field of cancer treatment, oncology, and immunotherapy

Class 005: Pharmaceutical products [ in the nature of chemicals ] for cancer treatment, oncology and immunotherapy; [ sanitary preparations for medical purposes; ] pharmaceutical products for human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy [ for auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Substances for medicinal use, namely, synthetic peptides for cancer treatment, oncology and immunotherapy, adjuvants for medical purposes, stem cells for medical purposes; Vaccines for treating cancer; vaccines; Substances for medicinal use, namely, serums for cancer treatment, oncology and immunotherapy, monoclonal antibodies for cancers, auto immune diseases and biological tissue grafts or skin grafts; Pharmaceutical products, namely, targeted therapies for cancers, auto immune diseases and biological tissue grafts or skin grafts ]; Class 042: [ Scientific and technological services, namely, research and design services in the fields of cancer treatment, oncology, immunotherapy; design and development of software and databases; medical research; biological and biotechnology research; pharmaceutical research; conducting clinical studies for others ]; Class 044: [ Medical services ]

Class 042: Research and development in the pharmaceutical and biopharmaceutical fields, namely, development of pharmaceuticals for the treatment of diseases with high morbidity and mortality rates

"BIOTHERAPEUTICS"; biological drug development being pharmaceutical or biopharmaceutical drug development services; biotechnology research services

"THERAPEUTICS"; Drug discovery and development services

Pharmaceutical products for the treatment of autoimmune diseases, neurodegenerative diseases, cancer, inflammatory diseases, and viral infections; "THERAPEUTICS"; Pharmaceutical research and development

Class 010: Medical devices; medical devices for psychotherapy treatment and neuropsychopharmacological treatment; therapeutic devices for use in psychotherapy treatment and neuropsychopharmacological treatment; diagnostic apparatus for medical purposes; dosage dispensers [measuring apparatus] for medical purposes, including for psychotherapy treatment and neuropsychopharmacological treatment; Class 044: Health and medical services; pharmacy and pharmacological services, including services relevant to the dispensing of pharmaceutical and medical psychedelic products, services and solutions; psychotherapy and neuropsychopharmacological treatment employing virtual reality technologies; therapy and wellness clinics incorporating psychedelic-assisted therapies; advisory services relevant to the health and medical industries, including providing information relevant to the accessibility of health and medical related services; Health assessment services; alternative medical services; alternative medicine services; mental health services; health care; psychiatry; psychiatric services; treatment of sleep disorders; services of a psychologist; rehabilitation services (health care and mental health care); remote monitoring of medical data for medical diagnosis and treatment; psychological diagnosis services; psychological examination; psychological testing for medical purposes; provision of information relating to behavioural modification, mental health and/or psychology; provision of medical assistance; preparing psychological profiles; preparation of psychological profiles for medical purposes; medical treatment services; hypnotherapy; health clinic services; complementary medical services; behavioural analysis for medical purposes; therapy services; health counselling; medical counselling; mental health counselling; lifestyle counselling (psychological therapy); psychological counselling; lifestyle counselling (medical advice); psychological or psychiatric counselling; information, consultancy and advisory services in respect of the aforementioned services

Class 042: Medical research services; Biotechnology research; Scientific research and development; Medical research laboratory services; Pharmaceutical research and development; Research and development of antibodies

Class 005: Antibodies for medical purposes; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders